chr12-57715782-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006812.4(OS9):c.602G>T(p.Gly201Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000528 in 1,610,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006812.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OS9 | NM_006812.4 | c.602G>T | p.Gly201Val | missense_variant | 6/15 | ENST00000315970.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OS9 | ENST00000315970.12 | c.602G>T | p.Gly201Val | missense_variant | 6/15 | 1 | NM_006812.4 | P4 | |
ENST00000549477.1 | n.534+5195C>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000724 AC: 18AN: 248684Hom.: 0 AF XY: 0.0000744 AC XY: 10AN XY: 134404
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1458354Hom.: 0 Cov.: 32 AF XY: 0.0000400 AC XY: 29AN XY: 725238
GnomAD4 genome AF: 0.000230 AC: 35AN: 152342Hom.: 0 Cov.: 32 AF XY: 0.000268 AC XY: 20AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.602G>T (p.G201V) alteration is located in exon 6 (coding exon 6) of the OS9 gene. This alteration results from a G to T substitution at nucleotide position 602, causing the glycine (G) at amino acid position 201 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at